Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna.. That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems where …
Read More »
Text size Maddie Meyer / Getty Images Moderna on Thursday lost a patent case that had been almost entirely overlooked as the stock increased due to excitement over the company’s Covid-19 vaccine, which will be tested in a large Phase 3 trial to begin. next week. What the decision issued …
Read More »
Text size Melinda Sue Gordon / Warner Brothers The release of another highly successful film has been delayed. However, studios have another option for movie release, even if they seem reluctant to use it. Warner Bros., the Hollywood studio owned by AT&T (ticker: T), delayed the release date of Beginning, …
Read More »
Text size Denis Charlet / AFP via Getty Images Microsoft released better-than-expected financial results for its fiscal fourth quarter as demand for its cloud-based software increased amid the pandemic-induced change to work and learn from home. For the quarter ended June 30, Microsoft (ticker: MSFT) posted revenue of $ 38 …
Read More »
As the S&P 500 falls into positive territory again throughout the year, investors need to be mindful of the fact that a handful of stocks appear to be doing much of the heavy lifting. The benchmark market index rose 1.3% in 2020 through Monday’s close, but much of that profit …
Read More »